Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923). [electronic resource]
Producer: 20030604Description: 248-57 p. digitalISSN:- 0923-7534
- Administration, Oral
- Adult
- Aged
- Antibiotic Prophylaxis
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carcinoma, Small Cell -- drug therapy
- Cost Savings
- Cost-Benefit Analysis
- Cyclophosphamide -- administration & dosage
- Double-Blind Method
- Doxorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Fever
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Health Care Costs -- statistics & numerical data
- Hospitalization -- statistics & numerical data
- Humans
- Incidence
- Leukopenia -- chemically induced
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Placebos -- administration & dosage
- Risk Factors
- Survival
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.